References
- Barddli A, Parsons DW. Silliman N, et al (2003). Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 300, 949. https://doi.org/10.1126/science.1082596
- Bentley OR (2006). Whole-genome re-sequencing. Curr Opin Genel Dev, 16,545-52. https://doi.org/10.1016/j.gde.2006.10.009
- Benvenuti S, Arena S, BardelliA (2005). Identification of cancer genes by mutational profiling of turnor genomes. FEBS Lea, 579, 1884-90. https://doi.org/10.1016/j.febslet.2005.02.015
- Bemstein BE, Meissner A, Lander ES (2007). The manunalian epigenome. Cell, 2, 669-81.
- Bird A (2007). Perceptions of epigenetics. Nalure, 447,396-8.
- Ding L, Getz G, Wheeler DA, et al (2008). Somatic mUlations affect key pathways in lung adenocarcinoma. Nature, 455,1069-75. https://doi.org/10.1038/nature07423
- Estecio MR, issa JP (2011 ). Dissecting DNA hypermethyiation in cancer. FEBS Letters, 585, 2078-86. https://doi.org/10.1016/j.febslet.2010.12.001
- Feber A (2010). Global profiling of methylation in the cancer genome. Cancer Genet Cytagenet, 203, 44-65.
- Fiers W, Contreras R, Duerinck F (1976). Complete nucleotidesequence of bacteriophage MS2-RNA - primary and secondary structure of replicase gene. Nature , 260, 500-7. https://doi.org/10.1038/260500a0
- Hanash SM, Pitteri SJ, Faca VM (2008). Mining the piasma proteome for cancer biomarkers. Nature, 452, 571 -9. https://doi.org/10.1038/nature06916
- Holliday R (1990). Mechanisms for the control of gene activity druingdevelopment. BiolRevCambr PhilosSoc, 65,431-71.
- Hoque MO, Kim MS, Ostrow KL, et al (2008). Genomewide promoter analysis uncovers portions of the cancer methylome. Cancer Res, 68, 2661-70. https://doi.org/10.1158/0008-5472.CAN-07-5913
- http://www.ncbi.nlm.nih.gov/genome.
- Hudson TJ, Anderson W, Artez A, et al (2010). International Cancer Genome Consortium International network of cancer genome projects. Nature, 464,993-8. https://doi.org/10.1038/nature08987
- Jones S, Hruban RH, Kamiyama M, et al (2009). Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science, 324, 217. https://doi.org/10.1126/science.1171202
- La Deana WH, Valerie R, Philip G, et al (2009). Massively parallel sequencing of the polyadenylated transcriptome of C. elegans. Genome Res, 19, 657-66. https://doi.org/10.1101/gr.088112.108
- Lander ES, Linton LM, Birren B, et al (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860-921. https://doi.org/10.1038/35057062
- Lay JO, Borgmann S, Liyanage R Wilkins CL(2006). Problems with the "omics". Trends in Analytical Chemistry, 25, 11 . https://doi.org/10.1016/j.trac.2005.04.019
- Laderberg J, McCray AT (2001). 'Ome Sweet 'Ontics -- A genealogical treasury of words. The Scientist, 15, 8.
- Li X, Shen S, Wu M, et at (2011 ). Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 36, 585-91.
- Moore LE, Pfeiffer RM, Zhang Z, et al (2012). Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using pre-diagnostic senun samples from the prostate lung colon and ovary (PLCO) cancer screening trial. Cancer, 118, 91-100. https://doi.org/10.1002/cncr.26241
- Morel NM, Holland lM, van der Greef J, et al (2004). Primer on medical genomics part XIV: Introduction to systems biology-A new approach to understanding disease and treatment. Maya Clin Proc, 79, 651-8. https://doi.org/10.4065/79.5.651
-
MUlTay S, Linardou H (2004). Proteomics and Cancer. STEP K
$\Lambda$ INIKHZ$\Sigma$ O$\Gamma$ KO$\Lambda$ O$\Gamma$ I$\Sigma$ , 3, 49-56. - Ng PC, Levy S, Huang J, et al (2008). Genetic variation in an individual human exome. PLoS Genetics, 4, 1000160. https://doi.org/10.1371/journal.pgen.1000160
- Olsvik O , Wahlberg J, Peuerson B, et al (1993).- Use of automated sequencing of polymerase chain reactiongenerated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol, 31,22-5.
- Pettersson E, Lundeberg J, Ahmadian A (2009). Generations of sequencing technologies. Genomics, 93, 105- 11. https://doi.org/10.1016/j.ygeno.2008.10.003
- Raphael BJ, Volik S, Collins C, Pevzner PA (2003). Reconstructing tumor genome architectures. Bioinformatics, 19, 162-71.
- Sanger F, Air GM, Barrell BG, et al (1977). Nucleotide sequence of bacteriophage phi X174 DNA. Nature, 265, 687-95. https://doi.org/10.1038/265687a0
- Sarah BN, Entily HT, Peggy DR, et al (2009), Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272-76. https://doi.org/10.1038/nature08250
- Schuster SC (2008). Next-generation sequencing transforms today's biology. Nat Methods, 5, 16-8. https://doi.org/10.1038/nmeth1156
- Shah Sp, MorinRD, Khattra J, et al (2009). Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature, 461, 809-13. https://doi.org/10.1038/nature08489
- Sjoblom T, Jones S, Wood LD, et al (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314,268-74. https://doi.org/10.1126/science.1133427
- Stadler ZK, Vijai J , Thorn P, el al (2010). Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am, 24, 973-96. https://doi.org/10.1016/j.hoc.2010.06.009
- Stephens PJ, McBride DJ, Lin ML, et al (2009). Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature, 462, 1005-10. https://doi.org/10.1038/nature08645
- Taguchi A, Politi K, Pitteri, et al (2011 ). Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell, 20, 289-99. https://doi.org/10.1016/j.ccr.2011.08.007
- Tripathi AK, Koringa PG , Jakhesara SJ, et al (2012). A preliminary sketch of horn cancer transcriplome in Indian zebu cattle. Gene, 1, 124-31.
- Varela I, Tarpey P, Rame K, et al (2011). Exome sequencing identifies frequentmutation of the SWUSNF complex gene PBRMI in renal carcinoma. Nature, 469, 539-42 https://doi.org/10.1038/nature09639
- Venter Cl, Adams DM, Myers WE, et at (2001). The sequence of the human genome. Science, 291, 1304-51. https://doi.org/10.1126/science.1058040
- Volik S, Zhao S, Chin K, et al (2003), End-sequence profiling: Sequence-based analysis of aberrant genomes. Proc Natl Acad Sci, 100, 7696-701. https://doi.org/10.1073/pnas.1232418100
- Wei X, Walia V, LinJC, et al (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nature Genetics, 43, 442-6. https://doi.org/10.1038/ng.810
- Weir BA, Michele S. Woo MS, Getz G, et al (2007). Characterizing the cancer genome in Iung adenocarcinoma. Nature, 450, 893-8. https://doi.org/10.1038/nature06358
- Wilkins MR, Appel R, Jennifer EVE, et al (1994), Guidelines for next 10 years of proteins. Proteomics, 6, 4-8.
Cited by
- Implementation of Proteomics for Cancer Research: Past, Present, and Future vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2433
- Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer vol.32, pp.3, 2014, https://doi.org/10.3892/or.2014.3277